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1. Introduction 
Urinary tract infection (UTI) is a common disease in children. In older children the clinical 
symptoms, diagnostic approach and treatment are similar to adults, whereas infants and 
neonates present with less specific symptoms. Children post renal transplantation/on 
immunosuppressive medication may also present with atypical symptoms. Therefore in this 
chapter we will focus on acute febrile urinary tract infections in young children (aged 2 
months to 2 years) and in children post renal transplantation (Tx).  
2. Definition  
Based on clinical symptoms, UTI’s can be divided into three different groups: asymptomatic 
bacteriuria (ABU), lower UTI (cystitis) and acute pyelonephritis (AP). AP is an infection of the 
kidney parenchyma and is the most severe form of UTI. In high risk populations (young 
children, Tx recipients) the AP can cause significant permanent kidney damage resulting in 
kidney function impairment (Rintaro Mori et al. 2007; Silva et al. 2010; Ramlakhan et al. 2011).  
3. Epidemiology 
The exact prevalence of UTI’s is difficult to assess due to heterogeneity of studies, which 
includes children of variable ages and genders. The prevalence of UTI’s among febrile 
young children presenting to the emergency department varies between 3.3 and 5.3%  
(Hoberman et al. 1993; Shaw et al. 1998).  
In contrast, the prevalence of febrile UTI in patients post Tx is much higher reaching 15-33% 
(John & Kemper 2009).  
4. Clinical symptoms 
High-grade fever is a common symptom of AP. Loin pain, dysuria and urinary frequency 
may be present, but in young children these symptoms are difficult to discern. Young 
children can present with only non specific symptoms such as irritability, vomiting, diarrhea 
and failure to thrive (Clark et al. 2010). 
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In young children a high grade fever (> 38°C) was found in 83% of patients diagnosed with 
AP, followed by poor feeding (28%), diarrhea (25%) and failure to thrive (15%) 
(Kanellopoulos et al. 2006). In children post Tx the most common clinical symptoms are 
fever, malaise, graft pain and impaired kidney function (John & Kemper 2009). 
5. Diagnosis 
An early and accurate diagnosis of AP in young children is very important but can be 
difficult. Delayed diagnosis and/or inadequate treatment of AP may increase the risk of 
possible permanent kidney damage (Fernández-Menéndez et al. 2003). On the other hand, a 
false diagnosis of AP may lead to invasive diagnostic imaging and unnecessary treatment 
without any benefit to the patient (Anon 1999). 
The diagnosis of AP is based on a positive urine culture (Mori et al. 2007; Anon 1999); 
therefore it is crucial to obtain a reliable urine sample for microbiology. The clean-catch 
urine sample (midstream urine) is appropriate in toilet-trained children, but may be difficult 
in younger children. In these patients, reliable urine samples can be obtained either by urine 
catheter or by suprapubic aspiration (SPA). However, both these methods are invasive and 
should be performed by skilled personnel (Clark et al. 2010). Therefore, an individualized or 
stepwise approach is recommended. If a child with symptoms suggesting AP is septic and 
requires immediate antibiotic treatment, the bladder catheterization or SPA is necessary. If 
however the patient with symptoms of UTI is not severely sick, a urine sample can be 
obtained by the most convenient method (for example adhesive urine bag) and sent for 
urinalysis and microscopy. If this urine sample is negative for leukocyte and nitrites, the 
likelihood of UTI is low (Mori et al. 2010; Ramlakhan et al. 2011); if however leucocytes 
and/nitrites are detected, a second urine sample should be obtained by a bladder catheter or 
SPA and sent for urine culture.  
Urine culture is considered positive if it grows ≥ 107 colony forming units (CFU) of one 
organism per liter of urine obtained by catheter or ≥ 108 CFU in mid-stream urine. Any 
quantity of a single organism in the urine obtained by SPA is considered a positive urine 
culture. The diagnosis of AP is usually based on a positive urine culture, high-grade fever, 
increased white blood cell count with a shift to the left and/or an elevated C-reactive 
protein.  
While these traditional tests suggest renal parenchymal involvement caused by the UTI, the 
extent and severity of parenchymal lesion/dysfunction is difficult to prove. Recently, serum 
procalcitonin level has emerged as a marker of parenchymal damage in UTI’s (Leroy & 
Gervaix 2011; Bressan et al. 2009).  
The dimercapto-succinic acid (DMSA) isotope exam has been considered as the gold 
standard to document renal parenchymal inflammation if performed within the first week 
of symptoms. This investigation is not performed routinely in every patient, but may be 
helpful in cases in which the diagnosis cannot be established based on urine culture, clinical 
and laboratory markers (for example a negative urine culture in children who were started 
on antibiotics before the urine sample was obtained)(Jaksic et al. 2010). 
The most predominant bacteria type causing AP in children is Escherichia coli. In the recent 
study from UK, E.coli caused 92% of acute UTI’s in children younger than five years, 
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followed by Proteus (3%) and Pseudomonas (2%)(Chakupurakal et al. 2010). In transplant 
patients, E coli is the cause of UTI’s in only 21-71 % of patients followed by Enterococcus sp 
(15-33%) and Pseudomonas aeruginosa (4-15%) (John & Kemper 2009). 
6. Treatment 
The choice of antibiotics for the treatment of AP should be done with respect to local 
resistance patterns. E. coli, the most common bacteria causing UTI’s in children, is usually 
susceptible to cephalosporins of the third generation or amoxicillin/clavulanate (Hodson et 
al. 2007). Recently published randomized controlled trials have shown that oral antibiotics 
are as effective as I.V. antibiotics in the treatment of AP (Pohl 2007; Hodson et al. 2007). I.V. 
treatment can be limited to children with persistent vomiting or who present seriously 
unwell; children can then be switched to oral antibiotics as soon as the clinical status allows. 
Antibiotic treatment should be started as soon as a reliable urine sample is sent for culture. 
The optimal duration of antibiotic therapy remains a matter of debate; at least 10 days are 
recommended for treatment of AP (Hodson et al. 2007).  
Long-term antibiotic prophylaxis after the first febrile uncomplicated UTI has been a matter of 
heated discussion among pediatricians/nephrologists and urologists. Most authors agree that 
it is generally not recommended in children with normal renal  ultrasound findings, as there is 
a lack of evidence of any benefit of prophylaxis for the prevention of relapses of symptomatic 
UTI and development of new kidney damage (Williams et al. 2006; Montini & Hewitt 2009). 
However, a recently published randomized controlled trial (RCT) showed that, in a subgroup 
of girls with high grade (III-IV) vesicoureteric reflux (VUR), those patients who received long 
term antibiotic prophylaxis, developed new scarring less often (Brandström et al. 2010). 
Another RCT showed a mild reduction in UTI recurrence in the prophylactic group and 
authors concluded that “it would be reasonable for clinicians to recommend the use of 
trimethoprim–sulfamethoxazole in children who are at high risk for infection or whose index 
infection was severe. Established risk factors for urinary tract infection are female gender, 
vesicoureteral reflux and particularly, recurrent urinary tract infection”(Craig et al. 2009). In 
view of these controversial opinions on antibiotic prophalaxis, it seems reasonable to consider 
prophylaxis on an individual basis, especially in girls.  
The antibiotic of choice for long-term prophylaxis is trimethoprim/sulfamethoxazole; the 
usual dose is 2 mg/kg of trimethoprim (TMP) given at bedtime. TMP alone can be used as 
an alternative, as its efficacy is the same as the combined TMP/sulfamethoxazole, but the 
TMP has less adverse effects (Nguyen et al. 2010). In children who do not tolerate or who 
develop resistance to TMP/ sulfamethoxazone, cephalosporins of the first or second 
generation (cefalexin, cefadroxil at dose of 10 mg/kg/per day (Saadeh & Mattoo 2011) ) or 
nitrofurantoin (1 mg/kg/day) can be considered.  
7. Imaging after the first febrile UTI 
The American Academy of Pediatrics recommends that children between the ages of 2 
months and 2 years undergo renal ultrasound (US) and voiding cystouretrography (VCUG) 
after the first febrile UTI (Anon 1999). This recommendation was based on the assumption 
that this imaging would allow the detection of children with obstructive uropathy and VUR 
who are at risk of recurrent UTI’s and, if untreated, at risk of permanent renal damage.  
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The widespread use of antenatal US in recent decades has significantly changed the pattern 
of congenital uropathies. Nowadays, the most severe cases are diagnosed antenatally and 
appropriate investigation and treatment is done during the neonatal period before these 
children develop a UTI. It is therefore questionable whether VCUG is really necessary in all 
children after their first febrile UTI. Recently published meta-analysis showed that a) the 
VUR was detected in 25% of children with the first febrile UTI, but only 2.5% of children 
had a high grade VUR (grade IV and V); b) the risk of renal scarring increases with the 
severity/grade of VUR (Shaikh et al. 2010). One may therefore assume that only patients 
with high grade VUR would be at risk for scarring. However, renal scars can develop even 
without the presence of VUR (Moorthy et al. 2005). It is therefore difficult to prove whether 
the scar is a result of UTI alone, or VUR or both. Overall, permanent renal scars have been 
found in 15% of children after the first UTI (Shaikh et al. 2010).  
Other studies in children with normal antenatal US report the incidence of renal scarring 
ranging between 4.5 to 16.9% (Garin et al. 2006; Hoberman et al. 2003; Shaikh et al. 2010). 
In view of the relatively high percentage of renal scarring post UTI, not necessarily related 
to the presence of VUR, it seems more important to focus on the detection of renal 
parenchymal damage, rather than detecting VUR at the time of the first UTI. Some authors 
therefore suggest to perform US and DMSA scans to detect renal scars and limit the VCUG 
in patients with evidence of renal scarring (Hardy & Austin 2008). The advantage of this so-
called top-down approach is that no patient with permanent kidney damage secondary to 
febrile UTI is missed and that the VCUG is indicated less often.  
In conclusion, UTI’s are relatively frequent in young children less than 2 years of age and in 
children post Tx, can present diagnostic dilemmas and may lead to kidney parenchymal 
damage if untreated or not treated properly in a timely fashion.  
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